Still should be higher by end of march
sounds like shorts desperate attempt to exit
Sentiment: Strong Buy
No secondary---pali drug sale post data.
much like KERX did...
They will wait until the runup into the march date to do that. They will be able to get a much higher price by then
Not necessary, funding lined up for next few years-- part of the reason why ZIOP is a best in breed-- little downside risk.